Company Filing History:
Years Active: 2015
Title: Sylvette Lachaud: Innovator in Anti-Cancer Compounds
Introduction
Sylvette Lachaud is a prominent inventor based in Paris, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-cancer compounds. With a total of 2 patents to her name, her work is paving the way for innovative treatments in oncology.
Latest Patents
Lachaud's latest patents focus on an anti-cancer compound and a pharmaceutical composition containing the same. The invention relates to a compound of formula (I), specifically in the levorotatory form (1a). This form has a rotatory power [α]D=−38.6+0.7 at a concentration of 0.698 mg/ml in methanol. The compound can exist as a base or an acid addition salt, particularly a pharmaceutically acceptable acid. It acts as a selective Aurora A and B kinase inhibitor, making it a potential candidate for anticancer drug development.
Career Highlights
Sylvette Lachaud is currently associated with Sanofi, a leading global healthcare company. Her work at Sanofi has allowed her to focus on groundbreaking research in the pharmaceutical sector. Her dedication to innovation has positioned her as a key player in the fight against cancer.
Collaborations
Lachaud has collaborated with notable colleagues, including Jean-Christophe Carry and Michel Cheve. These partnerships have enhanced her research efforts and contributed to the advancement of her inventions.
Conclusion
Sylvette Lachaud's contributions to the field of anti-cancer research are noteworthy. Her innovative patents and collaborations reflect her commitment to improving healthcare outcomes. As she continues her work, her inventions hold promise for future advancements in cancer treatment.